Journal
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY
Volume 26, Issue 5, Pages 573-580Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.bpg.2012.11.002
Keywords
IBS; Diarrhoea; Tricyclic agents; FODMAPs; Serotonin antagonists; Rifaximin; Loperamide; Probiotics
Categories
Ask authors/readers for more resources
IBS is a functional gastrointestinal disorder which has been subtyped according to bowel habits. This review presents recommendations for IBS-D which makes up about 1/3 of all patients and which is defined as IBS with loose or watery stools with >= 25% of bowel movements. Because IBS is a complex biopsychosocial illness, treatment cannot and should not be directed only to altered bowel habits. Evidence will be presented for dietary manipulations, probiotics and pharmacotherapies including tricyclic agents, antibiotics, serotonin antagonists and anti-diarrhoeal agents in the management of patients with IBS-D. (C) 2012 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available